Mitoxantrone hydrochloride liposome(Institute Of Hematology & Blood Diseases Hospital)

N/A

Report date: 2025/09/03 17:52:45

Base Information

Drug NameMitoxantrone hydrochloride liposome(Institute Of Hematology & Blood Diseases Hospital)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionHepatitis C virus serine protease, NS3/NS4A inhibitorsProto-oncogene serine/threonine-protein kinase Pim-1 inhibitorsTopoisomerase II inhibitors
TargetsTopoisomerase IIProto-oncogene serine/threonine-protein kinase Pim-1Hepatitis C virus serine protease, NS3/NS4A
Therapy Area/IndicationsLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesInstitute Of Hematology & Blood Diseases Hospital
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Hematology & Blood Diseases Hospital
Inactive CompaniesN/A
Active IndicationsLymphoma, Large B-Cell, Diffuse
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A